Latest CDC Autism Report - Rate Unchanged
Published : 2016-03-31
Author : Johns Hopkins University Bloomberg School of Public Health - Contact: jhu.edu
Synopsis* : New U.S. CDC report finds prevalence of autism spectrum disorders largely unchanged from 2 years ago, at 1 in 68 children or 1.46%.
Researchers at the Johns Hopkins Bloomberg School of Public Health contributed to a new U.S. Centers for Disease Control and Prevention (CDC) report that finds the prevalence of autism spectrum disorder (ASD) largely unchanged from two years ago, at one in 68 children (or 1.46 percent). Boys were 4.5 times more likely to be identified with ASD than girls, an established trend. The rate is one in 42 among boys and one in 189 among girls.
ASD is a developmental disorder characterized by social and communication impairments, limited interest and repetitive behaviors. Early diagnosis and intervention are important to improving learning and skills. Rates have been rising since the 1960s, but researchers do not know how much of this rise is due to more children being diagnosed with ASD or if actual cases are increasing or a combination of both. The CDC's first prevalance report, which was released in 2007 and was based on 2000 and 2002 data, found that one in 150 children had ASD.
For this new report, the CDC collected data at 11 regional monitoring sites that are part of the Autism and Developmental Disabilities Monitoring (ADDM) Network in the following states: Arkansas, Arizona, Colorado, Georgia, Maryland, Missouri, New Jersey, North Carolina, South Carolina, Utah, and Wisconsin. The Maryland monitoring site is based at the Johns Hopkins Bloomberg School of Public Health.
"Although we did not observe a significant increase in the overall prevalence rates in the monitoring sites, we continue to see the disparity among racial and ethnic groups," says Dr. Li-Ching Lee, PhD, ScM, a psychiatric epidemiologist with the Bloomberg School's departments of Epidemiology and Mental Health, and the principal investigator for the Maryland-ADDM. "For example, in Maryland, we found that Hispanic children were less likely to be evaluated for developmental concerns and therefore less likely to be identified."
In Maryland, Lee notes, the vast majority of children (95 percent) identified with ASD had a developmental concern in their records by age three, but only 55 percent of them received a comprehensive evaluation by age three. "This lag may delay the timing for children with ASD to get diagnosed and receive needed services," Lee says.
The prevalence in Maryland was one in 55 children (1.82 percent) with one in 34 among boys and one in 161 among girls. The data were derived from health and special education records of children who were eight years old and living in Baltimore County in 2012.
This is the sixth report by the CDC's Autism and Developmental Disabilities Monitoring Network (ADDM), which has used the same surveillance methods for more than a decade.
Estimated prevalence rates of ASD in the U.S. reported by previous data were:
- One in 68 children in the 2014 report that looked at 2010 data
- One in 88 children in the 2012 report that looked at 2008 data
- One in 110 children in the 2009 report that looked at 2006 data
- One in 150 children in the 2007 report that looked at 2000 and 2002 data
The researchers say it is too early to tell if the overall prevalence rate has stabilized because the numbers vary widely across ADDM communities. In communities where both health and education records were reviewed, the rates are from a low of 1.24% in parts of South Carolina to a high of 2.46% in parts of New Jersey.
Some trends in the latest CDC report data remain consistent, such as the greater likelihood of boys being diagnosed with ASD.
Disparities by race/ethnicity in estimated ASD prevalence, the age of earliest comprehensive evaluation and presence of a previous ASD diagnosis or classification persist. Specifically, non-white children with ASD are being identified and evaluated at a later age than non-Hispanic white children.
The majority of children identified with ASD by the ADDM Network (82 percent) had a previous ASD diagnosis or a special educational classification.
The causes of autism are not completely understood; studies show that both environment and genetics may play a role. There is no known cure, and no treatment or intervention has been proven to reduce the prevalence of ASD. The CDC recommends that parents track their child's development, act quickly and get their child screened if they have a concern. Free checklists and information for parents, physicians and child care providers are available at www.cdc.gov/ActEarly
A full copy of the report, "Prevalence of Autism Spectrum Disorder - Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012," is available on the CDC website here: www.cdc.gov/mmwr/volumes/65/ss/ss6503a1.htm
You're reading Disabled World. Be sure to check out our homepage for further informative disability news, reviews, disability sports events, exclusive stories and how-tos. You can also find us on Twitter, Facebook, and LinkedIn.
Related Autism Documents
- 1 - The Novel Coronavirus and Your Autistic Child : Dr. Lynette Louise offers tips to help relieve worry and ease health risks from COVID-19 when your child has autism.
- 2 - CARD Reacts to CDC Announcement of 15% Increase in Autism Rate : Autism Speaks state that the new numbers indicate a persistent undercount of autisms true prevalence among the nations children.
- 3 - Autism Prevalence Now Equals 1 in 59 American Children : Report published in CDC Morbidity and Mortality Weekly Report (MMWR) Surveillance Summary shows about 1 in 59 eight year-old children in 11 communities across the United States identified as having autism in 2014.
- 4 - Worldwide Free Online Course About Autism : Autism course will run from April 30 to June 1, 2018, the workload is around 2 hours a week and can be undertaken on-demand, all participants will receive a certificate upon completion.
- 5 - Autism's Social Deficits Reversed by Romidepsin Anti-Cancer Drug : Using an epigenetic mechanism, romidepsin restored gene expression and alleviated social deficits in animal models of autism.
*Disclaimer: Disabled World provides general information only. Materials presented are in no way meant to be a substitute for professional medical care by a qualified practitioner, nor should they be construed as such. Any 3rd party offering or advertising on disabled-world.com does not constitute endorsement by Disabled World. View our Advertising Policy for further information. Please report outdated or inaccurate information to us.
Journal: Disabled World. Language: English (U.S.). Author: Johns Hopkins University Bloomberg School of Public Health. Electronic Publication Date: 2016-03-31. Title: Latest CDC Autism Report - Rate Unchanged, Source: <a href=https://www.disabled-world.com/health/neurology/autism/unchanged.php>Latest CDC Autism Report - Rate Unchanged</a>. Retrieved 2021-05-09, from https://www.disabled-world.com/health/neurology/autism/unchanged.php - Reference: DW#293-12072.